Analysis of the prognostic role of plasmatic K-ras mutations in advanced non-small cell lung cancer (NSCLC) patients

被引：0
|
作者：
Sirera, R.
Camps, C.
Berrocal, A.
Munoz-Navarro, M.
Garcia-Gomez, R.
Vinolas, N.
Artal, A.
Guillot, M.
Taron, M.
Rosell, R.
机构：
[1] Hosp Gen Valencia, Valencia, Spain
[2] Hosp Gregorio Maranon, Madrid, Spain
[3] Hosp Clin Barcelona, Barcelona, Spain
[4] Hosp Miguel Servet, Zaragoza, Spain
[5] Hosp Son Dureta, Palma De Mallorca, Spain
[6] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18009
引用
收藏
页数：1
相关论文
共 50 条
  • [41] ANALYSIS OF KRAS MUTATIONS IN NON-SMALL CELL LUNG CANCER (NSCLC) BRAZILIAN PATIENTS
    Couto, Patricia G. P.
    Bastos-rodrigues, Luciana
    Sabato, Cristina
    Guieiro, Fernanda
    Vilhena, Alyne
    Amaral, Nilson F.
    De Marco, Luiz
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S735 - S736
  • [42] K-ras mutation predictive significance in platinum based chemotherapeutic protocols in patients with advanced non-small cell lung cancer
    Cvetkovic, Gordana
    Plavec, Goran
    Tomic, Ilija
    Llic, Vesna
    Magic, Zvonko
    Tatomirovic, Zeljka
    Novkovic, Dobrivoje
    Milic, Rade
    Karlicic, Vukojica
    VOJNOSANITETSKI PREGLED, 2009, 66 (02) : 149 - 155
  • [43] K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer
    Y Fukuyama
    T Mitsudomi
    K Sugio
    T Ishida
    K Akazawa
    K Sugimachi
    British Journal of Cancer, 1997, 75 : 1125 - 1130
  • [44] K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer
    Fukuyama, Y
    Mitsudomi, T
    Sugio, K
    Ishida, T
    Akazawa, K
    Sugimachi, K
    BRITISH JOURNAL OF CANCER, 1997, 75 (08) : 1125 - 1130
  • [45] Molecular staging of non-small cell lung cancer according to k-ras genotypes
    Rosell, R
    Monzo, M
    Pifarre, A
    Ariza, A
    Sanchez, JJ
    Moreno, I
    Maurel, J
    Lopez, MP
    Abad, A
    deAnta, JM
    CLINICAL CANCER RESEARCH, 1996, 2 (06) : 1083 - 1086
  • [46] Codon 12 K-ras mutations in plasma DNA are not an indicator of disease in non-small-cell lung cancer (NSCLC) patients.
    Betta, PG
    Trombino, S
    Angelini, C
    Neri, M
    Puntoni, R
    Filiberti, R
    Loprevite, M
    Orecchia, S
    Libener, R
    Russo, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 671S - 671S
  • [47] Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?
    Kim, Seung Tae
    Sung, Jae Sook
    Jo, Uk Hyun
    Park, Kyong Hwa
    Shin, Sang Won
    Kim, Yeul Hong
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [48] Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?
    Seung Tae Kim
    Jae Sook Sung
    Uk Hyun Jo
    Kyong Hwa Park
    Sang Won Shin
    Yeul Hong Kim
    Medical Oncology, 2013, 30
  • [49] CAN MUTATIONS OF EGFR AND KRAS OF SERUM BE PREDICTIVE AND PROGNOSTIC MARKERS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)?
    Kim, S. T.
    Kim, Y. H.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S66 - S66
  • [50] Prognostic significance and origin of plasma KRAS mutations in patients with non-small cell lung cancer (NSCLC)
    Gautschi, Oliver
    Ziegler, Annemarie
    Huegli, Barbara
    Gugger, Mathias
    Ratschiller, Daniel
    Mack, Philip C.
    Kung, Hsing-Jien
    Stahel, Rolf A.
    Gandara, David R.
    Betticher, Daniel C.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S443 - S443
12345